Acetylcholine receptor antibody-positive myasthenia gravis and Kennedy’s disease overlap syndrome: a case report and literature review - Report - MDSpire

Acetylcholine receptor antibody-positive myasthenia gravis and Kennedy’s disease overlap syndrome: a case report and literature review

  • By

  • Guo-hui Gao

  • Yu-qing Xu

  • Yu-dong Liu

  • Ying Liu

  • Jing Yuan

  • June 11, 2026

  • 0 min

Share

Clinical Report: Overlap Syndrome of AChR Antibody-Positive MG and KD

Overview

This report presents a unique case of overlap syndrome involving acetylcholine receptor antibody-positive myasthenia gravis and Kennedy’s disease. The findings highlight the importance of recognizing this rare condition to improve diagnosis and management.

Background

Myasthenia gravis (MG) is an autoimmune disorder characterized by fluctuating muscle weakness due to autoantibodies against the neuromuscular junction. Kennedy’s disease (KD) is a rare motor neuron disorder caused by mutations in the androgen receptor gene. The coexistence of these two conditions is exceptionally rare, making this case significant for clinical awareness and understanding of potential comorbid mechanisms.

Data Highlights

The patient exhibited clinical features of both MG and KD, with neurophysiological findings consistent with KD. Genetic testing confirmed the diagnosis of KD, with a notable CAG repeat expansion in the androgen receptor gene.

Key Findings

  • The patient was a 60-year-old male with diplopia and bilateral ptosis, symptoms that worsened with fatigue.
  • Neurophysiological assessments revealed significant neurogenic changes consistent with Kennedy’s disease.
  • Genetic testing showed an abnormal CAG repeat length in the androgen receptor gene, confirming the diagnosis of KD.
  • Literature review identified only four previous cases of KD with myasthenic features, all of which were AChR antibody-negative.
  • This case represents the first genetically confirmed instance of AChR antibody-positive MG coexisting with KD.

Clinical Implications

Clinicians should be aware of the potential for overlap syndromes in patients presenting with symptoms of MG and KD. Early recognition and appropriate diagnostic testing can facilitate better management strategies for affected individuals.

Conclusion

The overlap syndrome of AChR antibody-positive MG and Kennedy’s disease underscores the need for heightened clinical awareness and further research into the mechanisms underlying these rare coexisting conditions.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Author(s)/Org, Source, Year -- Title
  6. Author(s)/Org, Source, Year -- Title
  7. 271st ENMC international workshop: Towards a unifying effort to fight Kennedy's disease. 20-22 October 2023, Hoofddorp, Netherlands
  8. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update - PMC
  9. Long-Term Efficacy and Safety of Ravulizumab in Adults With Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open-Label Extension
  10. 271st ENMC international workshop: Towards a unifying effort to fight Kennedy's disease. 20-22 October 2023, Hoofddorp, Netherlands

Original Source(s)

Related Content